-
1
-
2
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
Published 2022-06-01Get full text
Article -
3
Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative Review
Published 2022-10-01Get full text
Article